Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Ovid Therapeutics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 55 | 59 | +4 |
| Shares | 34.6M | 35.6M | +963.3K (+2.8%) |
| Value | $74.5M | $65.5M | −$8.96M (−12.0%) |
New holders (10)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Madison Avenue Partners, LP | 1,394,022 | $2.56M | 0.55% |
| Dimensional Fund Advisors LP | 41,720 | $77.0K | 0.00% |
| Balyasny Asset Management LLC | 31,938 | $59.0K | 0.00% |
| Mariner, LLC | 19,000 | $35.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 15,522 | $29.0K | 0.01% |
| Bailard, Inc. | 11,800 | $22.0K | 0.00% |
| Virtu Financial LLC | 10,347 | $19.0K | 0.00% |
| Royal Bank of Canada | 459 | $1.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 660 | $1.00K | 0.00% |
| State of Wyoming | 76 | $0 | 0.00% |
Sold out (6)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| First Trust Advisors LP | 80,907 | $174.0K |
| Ikarian Capital, LLC | 26,831 | $59.0K |
| Assenagon Asset Management S.A. | 26,362 | $57.0K |
| Squarepoint Ops LLC | 10,543 | $23.0K |
| Optimum Investment Advisors | 2,000 | $4.00K |
| Simplex Trading, LLC | 99 | $0 |